Advitech Signs a Definitive Distribution Agreement for Mexico With a Pharmaceutical Leader in Dermatology
08 January 2008
Advitech Inc. announces the conclusion of a definitive agreement for the distribution of DermylexTM on the Mexican market with Laboratorios Dermatologicos Darier SA de CV ("Darier"), a pharmaceutical leader in dermatology, specialized in the development and commercialization of prescription and cosmeceutical products.
"This is a breakthrough agreement for Advitech with Darier, a leading Mexican pharmaceutical company specializing in dermatology, as it constitutes our second commercial partnership with a pharmaceutical company specializing in dermatology," commented Mr Renaud Beauchesne, President and Chief executive officer of Advitech.
"This is a significant partnership for Advitech as it further validates our clinical data and program on Dermylex™. It also reinforces our business strategy, which is to focus mainly on dermatology-oriented distributors, and it acknowledges the effectiveness of our patented XP-828L technological platform," added Mr Beauchesne.
Mr Fernando Ahumada, President and Chief executive officer of Darier added: "Laboratorios Dermatologicos Darier is the Mexican leader in dermatology and with the help of Dermylex; we intend to increase our market share in psoriasis and collaborate with Advitech to investigate additional opportunities in dermatology in the Mexican market."
